Clinical Trial Update: Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of ipilimumab and all-trans retinoic acid in advanced melanoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• ipilimumab (ipilimumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2019-07-16